TAVR Improves Outcomes in Bioprosthetic Aortic Valve Failure With High Surgical Risk
A study was conducted to evaluate and report valve-in-valve transcatheter aortic valve replacement outcomes at 5 years.
A study was conducted to evaluate and report valve-in-valve transcatheter aortic valve replacement outcomes at 5 years.
Researchers sought to compare use of transcatheter aortic valve replacement among White, Black, and Hispanic patients with aortic stenosis.
A retrospective study was conducted to examine 3-year complications among patients with obstructive sleep apnea who received transcatheter aortic valve replacement.
A study compared clinical characteristics and outcomes between patients with TAVI-IE treated with cardiac surgery and antibiotics and those treated with antibiotics only.
Aortic stenosis is a condition in which the opening of the aortic valve narrows, restricting blood flow from the heart to the rest of the body. The American Heart Association estimates that over 20% of older Americans have aortic stenosis, referring to it as a condition “common in people over age 65.”¹ Despite its prevalence,…
The presence of AF after TAVR may be associated with changes in left ventricular mass index.
Transcatheter aortic valve replacement in failed TAVs was found to be associated with greater procedural success than TAV in failed surgical aortic valve.
In 2019, TAVR exceeded surgical procedures; 30-day mortality and stroke rates decreased since 2011.
The Emory risk score was found to have modest value for predicting permanent pacemaker implantation.
Coronary cannulation failures following transcatheter aortic valve replacement were found to be higher in patients receiving Evolut TAVs.